These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 39216610)
21. People with older age and lower FEV1%pred tend to have a smaller FVC than VC in pre-bronchodilator spirometry. Wang W; Ma D; Li T; Ying Y; Xiao W Respir Physiol Neurobiol; 2014 Apr; 194():1-5. PubMed ID: 24448311 [TBL] [Abstract][Full Text] [Related]
22. Prediction of Acute COPD Exacerbation in the Swiss Multicenter COPD Cohort Study (TOPDOCS) by Clinical Parameters, Medication Use, and Immunological Biomarkers. Huebner ST; Henny S; Giezendanner S; Brack T; Brutsche M; Chhajed P; Clarenbach C; Dieterle T; Egli A; Frey M; Heijnen I; Irani S; Sievi NA; Thurnheer R; Trendelenburg M; Kohler M; Leuppi-Taegtmeyer AB; Leuppi JD Respiration; 2022; 101(5):441-454. PubMed ID: 34942619 [TBL] [Abstract][Full Text] [Related]
23. Combined Forced Expiratory Volume in 1 Second and Forced Vital Capacity Bronchodilator Response, Exacerbations, and Mortality in Chronic Obstructive Pulmonary Disease. Fortis S; Comellas A; Make BJ; Hersh CP; Bodduluri S; Georgopoulos D; Kim V; Criner GJ; Dransfield MT; Bhatt SP; Ann Am Thorac Soc; 2019 Jul; 16(7):826-835. PubMed ID: 30908927 [No Abstract] [Full Text] [Related]
24. Plasma Inflammatory Cytokine IL-4, IL-8, IL-10, and TNF-α Levels Correlate with Pulmonary Function in Patients with Asthma-Chronic Obstructive Pulmonary Disease (COPD) Overlap Syndrome. Huang AX; Lu LW; Liu WJ; Huang M Med Sci Monit; 2016 Aug; 22():2800-8. PubMed ID: 27501772 [TBL] [Abstract][Full Text] [Related]
25. Prognostic marker for severe acute exacerbation of chronic obstructive pulmonary disease: analysis of diffusing capacity of the lung for carbon monoxide (D Choi J; Sim JK; Oh JY; Lee YS; Hur GY; Lee SY; Shim JJ; Rhee CK; Min KH BMC Pulm Med; 2021 May; 21(1):152. PubMed ID: 33957906 [TBL] [Abstract][Full Text] [Related]
26. Differences in clinical significance of bronchodilator responses measured by forced expiratory volume in 1 second and forced vital capacity. Choi JY; Kim SK; Lee JH; Jung KS; Yoo KH; Hwang KE; Lee JD; Kim YI; Yoon HK; Um SJ PLoS One; 2023; 18(2):e0282256. PubMed ID: 36827406 [TBL] [Abstract][Full Text] [Related]
27. Structural features on quantitative chest computed tomography of patients with maximal mid-expiratory flow impairment in a normal lung function population. Yang Y; Ge H; Lu J; Huang X; Wang K; Jin L; Qi L; Li M BMC Pulm Med; 2023 Mar; 23(1):86. PubMed ID: 36922831 [TBL] [Abstract][Full Text] [Related]
28. Clinical Characteristics and Frequency of Chronic Obstructive Pulmonary Disease Exacerbations in Korean Patients: Findings From the KOCOSS Cohort 2012-2021. Rhee CK; Choi JY; Park YB; Yoo KH J Korean Med Sci; 2024 May; 39(19):e164. PubMed ID: 38769923 [TBL] [Abstract][Full Text] [Related]
30. Lung Function and the Risk of Exacerbation in the β-Blockers for the Prevention of Acute Exacerbations of Chronic Obstructive Pulmonary Disease Trial. Parekh TM; Helgeson ES; Connett J; Voelker H; Ling SX; Lazarus SC; Bhatt SP; MacDonald DM; Mkorombindo T; Kunisaki KM; Fortis S; Kaminsky D; Dransfield MT Ann Am Thorac Soc; 2022 Oct; 19(10):1642-1649. PubMed ID: 35363600 [No Abstract] [Full Text] [Related]
31. Characteristics Associated with Accelerated Lung Function Decline in a Primary Care Population with Chronic Obstructive Pulmonary Disease. Whittaker HR; Pimenta JM; Jarvis D; Kiddle SJ; Quint JK Int J Chron Obstruct Pulmon Dis; 2020; 15():3079-3091. PubMed ID: 33268984 [TBL] [Abstract][Full Text] [Related]
32. Shear wave elastography of the diaphragm in acute exacerbation of chronic obstructive pulmonary disease: A prospective observational study. Zhang J; Zhang C; Yan L; Zhang L; Wan Y; Wang Q; Wang P; Xu J Medicine (Baltimore); 2023 Mar; 102(11):e33329. PubMed ID: 36930088 [TBL] [Abstract][Full Text] [Related]
33. What is the difference between FEV1 change in percentage predicted value and change over baseline in the assessment of bronchodilator responsiveness in patients with COPD? Jian W; Zheng J; Hu Y; Li Y; Gao Y; An J J Thorac Dis; 2013 Aug; 5(4):393-9. PubMed ID: 23991293 [TBL] [Abstract][Full Text] [Related]
34. Annual rates of change in pre- vs. post-bronchodilator FEV1 and FVC over 4 years in moderate to very severe COPD. Tashkin DP; Li N; Halpin D; Kleerup E; Decramer M; Celli B; Elashoff R Respir Med; 2013 Dec; 107(12):1904-11. PubMed ID: 23972968 [TBL] [Abstract][Full Text] [Related]
35. Relationship between pulmonary function and albuminuria in type 2 diabetic patients with preserved renal function. He YY; Chen Z; Fang XY; Chang J; Lu Y; Wang XJ BMC Endocr Disord; 2020 Jul; 20(1):112. PubMed ID: 32703207 [TBL] [Abstract][Full Text] [Related]
36. Quantitative Evaluation of Chronic Obstructive Pulmonary Disease and Risk Prediction of Acute Exacerbation by High-Resolution Computed Tomography. Hua Q; Chen G; Yang Y; Leng S; Zhao Z; Bai F; Hu X; Qiu L; Yu Z; Zhang H; Shi J; Dai Q Evid Based Complement Alternat Med; 2022; 2022():6015766. PubMed ID: 35865341 [TBL] [Abstract][Full Text] [Related]
37. Application Value of Broadband 3-Dimensional Impulse Oscillometry in COPD. Tang Z; Li M; Chu G; Mou Y; Chen Q; Zhu H Int J Chron Obstruct Pulmon Dis; 2021; 16():215-223. PubMed ID: 33574662 [TBL] [Abstract][Full Text] [Related]
38. Cut-off value of FEV1/FEV6 as a surrogate for FEV1/FVC for detecting airway obstruction in a Korean population. Chung KS; Jung JY; Park MS; Kim YS; Kim SK; Chang J; Song JH Int J Chron Obstruct Pulmon Dis; 2016; 11():1957-63. PubMed ID: 27578970 [TBL] [Abstract][Full Text] [Related]
39. Maximal mid-expiratory flow detects early lung disease in α Stockley JA; Ismail AM; Hughes SM; Edgar R; Stockley RA; Sapey E Eur Respir J; 2017 Mar; 49(3):. PubMed ID: 28356373 [TBL] [Abstract][Full Text] [Related]